Newborn Vitamin K Shot: Why It Matters

A routine injection given shortly after birth is drawing increasing scrutiny from parents—and increasing concern from pediatricians.

Vitamin K has been routinely recommended for newborns for decades because babies are naturally born with very low stores of the vitamin. Without enough vitamin K, a baby’s blood may not clot properly, creating the risk of vitamin K deficiency bleeding, or VKDB. In rare cases, that bleeding can occur inside the brain and become life-threatening.

Dr. Anthony Oraha, Founder and CEO of Synergy Longevity Centers, recently discussed the issue on FOX 2 Detroit and why better education—not fear or judgment—needs to be part of the solution.

Watch Dr. Anthony Oraha discuss newborn vitamin K on FOX 2 Detroit

Why Are Babies Born With Low Vitamin K?

Vitamin K plays an essential role in activating several proteins the body uses to form blood clots.

Adults obtain vitamin K through food and intestinal bacteria. Newborns are different. Only small amounts of vitamin K cross the placenta during pregnancy, babies are born before vitamin-K-producing intestinal bacteria become established, and breast milk naturally contains relatively low concentrations of vitamin K.

As a result, essentially all newborns begin life with low vitamin K stores.

The standard intramuscular vitamin K injection provides a reserve that protects the baby while these natural sources develop.

Importantly, vitamin K is not a vaccine. It does not contain a virus or bacteria and is not designed to stimulate the immune system. It is supplementation of a vitamin newborns naturally lack.

What Is Vitamin K Deficiency Bleeding?

Without enough vitamin K, newborns can develop VKDB, in which the blood cannot clot normally.

The CDC divides VKDB into early, classic and late forms. Early and classic VKDB occur in approximately 1 in 60 to 1 in 250 newborns without adequate prophylaxis, while late VKDB is much less common, occurring in roughly 1 in 14,000 to 1 in 25,000 infants who do not receive the vitamin K shot.

Late VKDB is particularly concerning because it can appear weeks or even months after birth in a baby who previously seemed completely healthy.

Approximately 30% to 60% of late VKDB cases involve bleeding inside the brain, according to the CDC. Warning signs may also be absent before the first serious bleeding event. Babies who do not receive the vitamin K injection are estimated to be 81 times more likely to develop late VKDB than babies who receive it.

The absolute risk is relatively small. But the potential consequence—intracranial hemorrhage, neurologic injury or death—is why pediatric organizations continue to recommend prevention.

Why Are More Parents Declining Vitamin K?

This question deserves more nuance than simply labeling parents as “anti-medicine.”

A Reuters analysis published in September 2026 found that the percentage of U.S. hospital newborns not receiving vitamin K within a day of birth reached 8.1% by the end of June 2026, compared with 5.2% six months earlier. The analysis included more than one million births.

Research examining parental refusal has identified several recurring concerns: questions about ingredients, fear of side effects, a preference for a more natural birth experience, a belief that vitamin K is unnecessary, and information encountered online.

Some parents also mistakenly group vitamin K together with childhood vaccinations even though the two interventions work completely differently.

The appropriate response is not to shame parents for asking questions. Parents should ask questions about treatments being given to their children.

The responsibility of healthcare professionals is to make sure those questions receive accurate answers.

The Conversation Should Start Before the Delivery Room

This may be one of the most important lessons from the growing refusal rate.

Imagine hearing about vitamin K for the first time immediately after delivering a baby. Parents may be exhausted, emotional and suddenly asked to authorize an injection they have never researched.

That is not an ideal environment for informed decision-making.

The CDC specifically encourages healthcare providers to discuss vitamin K with expectant parents before they reach the delivery room. Research published through the American Academy of Pediatrics has similarly concluded that education should begin during the prenatal period and directly address the concerns parents are encountering online.

Obstetricians, pediatricians and other members of the prenatal care team have an opportunity to explain why vitamin K is recommended, what is in the injection, what its known risks are, and what risk parents accept if they decline it.

Better informed consent means having that conversation before the decision becomes urgent.

Is the Vitamin K Shot Safe?

Vitamin K has been recommended for newborns by the American Academy of Pediatrics since 1961.

A study published in the early 1990s raised concern about a possible association between injected vitamin K and childhood cancer. That appropriately prompted additional research. Larger subsequent studies did not reproduce the association, and current evidence does not support a causal relationship between the vitamin K injection and leukemia or other childhood cancers.

Parents sometimes also ask whether oral vitamin K can replace the injection. Oral regimens are used in some countries, but they require repeated dosing and have generally been less effective at preventing VKDB than intramuscular vitamin K. The AAP continues to recommend intramuscular prophylaxis for newborns.

The Bottom Line

Most babies who do not receive vitamin K will never experience a catastrophic bleeding event. That context matters.

But prevention is about understanding both probability and consequence.

Vitamin K deficiency bleeding is uncommon, yet it can occur without warning in an otherwise healthy infant and can lead to brain injury or death. A single vitamin K injection dramatically reduces that risk.

Parents asking questions should never be viewed as the problem. The larger challenge is making sure reliable medical information reaches families before misinformation does.

Preventive medicine works best when patients understand not only what is being recommended, but why.

Expectant parents with questions about vitamin K should discuss them with their obstetrician and pediatrician during pregnancy rather than waiting until delivery.

This article is for educational purposes only and is not a substitute for individualized medical advice. Decisions regarding newborn care should be discussed with your obstetric and pediatric healthcare teams.